Mark Earl Hensley
Chief Operating Officer, HERON THERAPEUTICS, INC. /DE/.
Companies
- HERON THERAPEUTICS, INC. /DE/Chief operating officer Apr 29, 2025 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- HERON THERAPEUTICS, INC. /DE/ HRTX170,901 shares2$64.9K at $0.38Aug 6, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 6, 2026Shares withheld for tax 8,888 shares at $0.50 of HERON THERAPEUTICS, INC. /DE/2
- Aug 6, 2026Exercised options 31,250 shares of HERON THERAPEUTICS, INC. /DE/2
- Jul 31, 2026Exercised options 11,769 shares of HERON THERAPEUTICS, INC. /DE/3
- May 6, 2026Exercised options 125,000 shares of HERON THERAPEUTICS, INC. /DE/4
- Apr 30, 2026Exercised options 11,770 shares of HERON THERAPEUTICS, INC. /DE/5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Aug 3, 2026
- 4SEC EDGARForm 4 filed May 7, 2026
- 5SEC EDGARForm 4 filed May 4, 2026